KRISTIN BROWN: Open Payments
NPI 1841427929 · MOORESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,535 in 169 payments from 18 companies in 2025. Trend: 2023 $2,298 · 2024 $1,982 · 2025 $2,535
Food & beverage: $2,472Education: $64
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 26 | $441 |
| ABBVIE INC. | 57 | $425 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $343 |
| Otsuka America Pharmaceutical, Inc. | 11 | $245 |
| E.R. Squibb & Sons, L.L.C. | 12 | $227 |
| Neurocrine BioSciences, Inc. | 8 | $174 |
| Axsome Therapeutics, Inc. | 12 | $135 |
| Alkermes, Inc. | 5 | $107 |
| Lundbeck LLC | 4 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $63 |
Products named: AUSTEDO XR, VRAYLAR, CAPLYTA, REXULTI, COBENFY, INGREZZA, Auvelity, ARISTADA.
Industry payments across NC — which companies pay providers there.
